Biotech Values

[poorgradstudent]

You have an interesting schema.

I suspect most people on this board are too nice to really give the PPHM folks their honest, uncensored view of the PPHM drug and clinical results to date. Mostly because I'm sure you're all very nice people and posters don't want to come off confrontational with you, and partly because they feel they'd be spitting in the wind. But because of that, we keep going on in circles with the latest PPHM distraction... and that's what all this stuff is: a distraction to avert people away from an inefficacious drug.

And before you scoff at how brusquely I dismiss PPHM, do realize that I went through this with Cell Pathways many years ago. Hedge funds conspiring against it, Pazdur supposedly threatening the CEO, they also had a pivotal trial where the CRO messed up, conspiracies related to PFE wanting to protect their Celebrex franchise, the CEO whispering to certain people on message boards, the IR people reading the message boards and answering message board conspiracies and naive misconceptions.

Been there, done that.

Back then, I responded to negative data the exact same way that PPHM investors appear to do. By ignoring it, pointing vaguely to authority, bending over backwards to find comparator data that satisfies my pre-conceived notion, and buying into distractions that were simply working to keep me from delving into the clinical data and regulatory landscape. I basically did everything in my power to ignore the clinical data and what it objectively said.

I'd write a book about the experience, but the irony is that the people who would most need to read it are the exact people who would never do so. I know, because back then I wouldn't have either.